State-of-the-art tools to identify druggable protein ligand of SARS-CoV-2

INTRODUCTION: The SARS-CoV-2 (previously 2019-nCoV) outbreak in Wuhan, China and other parts of the world affects people and spreads coronavirus disease 2019 (COVID-19) through human-to-human contact, with a mortality rate of > 2%. There are no approved drugs or vaccines yet available against SAR...

Descripción completa

Detalles Bibliográficos
Autores principales: Azeez, Sayed Abdul, Alhashim, Zahra Ghalib, Al Otaibi, Waad Mohammed, Alsuwat, Hind Saleh, Ibrahim, Abdallah M., Almandil, Noor B., Borgio, J. Francis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212236/
https://www.ncbi.nlm.nih.gov/pubmed/32399095
http://dx.doi.org/10.5114/aoms.2020.94046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212236/
https://www.ncbi.nlm.nih.gov/pubmed/32399095
http://dx.doi.org/10.5114/aoms.2020.94046

Ejemplares similares